ATTENTION DEFICIT HYPERACTIVITY DISORDER TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Attention Deficit Hyperactivity Disorder Treatment Market, By Drug Type (Stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, Lisdexamfetamine Dimesylate), Non-stimulants (Atomoxetine, Bupropion, Guanfacine, Clonidine)), By Age Group (Pediatric and Adolescent, Adult), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In: 05 Feb, 2026
Code: CMI830
Page number: 152
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

The global attention deficit hyperactivity disorder (ADHD) treatment market comprises therapeutics used for the treatment of attention deficit hyperactivity disorder. There are various therapeutics such as stimulants, which include stimulant drugs such as Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate and non-stimulant drugs such as Atomoxetine, Bupropion, Guanfacine, and Clonidine. There are three types of attention deficit hyperactivity disorder (ADHD) such as predominantly inattentive presentation, predominantly hyperactive-impulsive presentation, and combined presentation. Various causes of attention deficit hyperactivity disorder (ADHD) include brain injury, alcohol and tobacco use during pregnancy, premature delivery, and low birth weight. It is a chronic condition which affects millions of children and often continue until the adulthood. Children with attention deficit hyperactivity disorder often suffer and struggle with low self-esteem and poor performance in school. Attention deficit hyperactivity disorder are not curable but can deal with symptoms. Treatment of attention deficit hyperactivity disorder involves medications as well as behavioral intervention. ADHD mainly have symptoms of inattention. ADHD probably results from a combination of factors such as genetics, researchers are looking at possible environmental factors that might raise the risk of developing ADHD and are studying how brain injuries, nutrition, and social environments might play a role in ADHD.

Market Dynamics

Key players are focusing on technological advancements to strengthen their position in the global attention deficit hyperactivity disorder (ADHD) treatment market. For instance, in June 2020, Akili Interactive Labs, a digital medicine prescription company received the U.S. Food Drug and Administration clearance for EndeavorRxTM (AKL-T01), a prescription medicine treatment for children with attention deficit hyperactivity disorder (ADHD). EndeavorRxTM is used to treat and to improve attention in children suffering from ADHD.

Key features of the study

This report provides an in-depth analysis of the global attention deficit hyperactivity disorder treatment market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global attention deficit hyperactivity disorder treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amnel Pharmaceuticals LLC., Eli Lilly And Company, Johnson & Johnson Services, Inc., Noven Pharmaceuticals, Inc, RespireRx Pharmaceuticals Inc, Otsuka Pharmaceutical Co., Ltd, Neos Therapeutics, Inc., American Brivision (Holding) Corporation, Novartis AG, Takeda Pharmaceutical Company Limited, GSK plc, Purdue Pharma L.P. ,Cingulate, Adlon Therapeutics L.P., Tris Pharma, Inc.,Neuraxpharm, Supernus Pharmaceuticals,Inc., and Aytu Biopharma, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global attention deficit hyperactivity disorder treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global attention deficit hyperactivity disorder treatment market

Market Segmentation

Drug Type Insights (Revenue, USD Mn, 2026 - 2033)
- Stimulants
  - Amphetamine
  - Methylphenidate
  - Dextroamphetamine
  - Dexmethylphenidate
  - Lisdexamfetamine Dimesylate
- Non-stimulants
  - Atomoxetine
  - Bupropion
  - Guanfacine
  - Clonidine
Age Group Insights (Revenue, USD Mn, 2026 - 2033)
- Pediatric and Adolescent
- Adult
Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Amnel Pharmaceuticals LLC.
- Eli Lilly And Company
- Johnson & Johnson Services, Inc.
- Noven Pharmaceuticals, Inc
- RespireRx Pharmaceuticals Inc
- Otsuka Pharmaceutical Co. Ltd
- Neos Therapeutics, Inc.
- American Brivision (Holding) Corporation
- Novartis AG
- Takeda Pharmaceutical Company Limited
- GSK plc
- Purdue Pharma L.P.Cingulate
- Adlon Therapeutics L.P.
- Tris Pharma, Inc.
- Neuraxpharm
- Supernus Pharmaceuticals, Inc.
- Aytu Biopharma, Inc

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snapshot, By Drug Type
Market Snapshot, By Age Group
Market Snapshot, By Distribution Channel
Market Snapshot, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Regulatory Scenario
Pricing Analysis
Brand Mapping
Pipeline Analysis
PEST Analysis

Global Attention Deficit Hyperactivity Disorder Treatment Market, By Drug Type, 2026-2033, (USD Mn)

Overview

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Stimulants

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Amphetamine
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
Lisdexamfetamine Dimesylate

Non-Stimulants

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Atomoxetine
Bupropion
Guanfacine
Clonidine

Global Attention Deficit Hyperactivity Disorder Treatment Market, By Age Group, 2026-2033, (USD Mn)

Overview

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Pediatric and Adolescent

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Adult

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Global Attention Deficit Hyperactivity Disorder Treatment Market, By Distribution Channel, 2026-2033, (USD Mn)

Overview

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Hospital Pharmacies

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Retail Pharmacies

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Online Pharmacies

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Global Attention Deficit Hyperactivity Disorder Treatment Market, By Region, 2026-2033, (USD Mn)

Introduction

Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033

North America

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)

U.S.
Canada

Latin America

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)

Brazil
Mexico
Argentina
Rest of Latin America

Europe

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)

GCC
Israel
Rest of Middle East

Africa

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
Market Size and Forecast, By Country, 2026-2033, (USD Mn)

North Africa
Central Africa
South Africa

Competitive Landscape

Amnel Pharmaceuticals LLC.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Eli Lilly And Company

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Johnson & Johnson Services, Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Noven Pharmaceuticals, Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

RespireRx Pharmaceuticals Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Otsuka Pharmaceutical Co., Ltd.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Neos Therapeutics, Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

American Brivision (Holding) Corporation

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Novartis AG

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Takeda Pharmaceutical Company Limited

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

GSK plc

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Purdue Pharma L.P.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Cingulate

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Adlon Therapeutics L.P.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Tris Pharma, Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Neuraxpharm

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Supernus Pharmaceuticals, Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Aytu Biopharma, Inc.

Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

Section

Research Methodology
About Us

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now